TNF and serum lipopolysaccharide activity: In conclusion, our findings indicate that glibenclamide could ameliorate myocardial injury and reducing IL-1β and TNF-α possibly through inhibiting Nalp3 inflammasomes and Caspase-1 signaling under LPS-induced endotoxemia in STZ diabetic mice.